Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 7 of 31
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
NCT02270814
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
NCT02253316
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
NCT02204098
Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts
NCT02181257
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
NCT01790373
Immune Disorder HSCT Protocol
NCT01821781
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
NCT01723774
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
NCT01760005
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
NCT01061515
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
NCT01104220
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
NCT00882895
Phase II Trial Evaluating Elimination of Radiation Therapy
NCT00593840
PET Imaging in Parkinson Disease Dementia
NCT01052350
Prostate Cancer Prospective Cohort
NCT00937586
TeamTalk: Improving Inter-professional Communication During Cancer Treatment
NCT07083674
Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia
NCT07682792
Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
NCT07662031
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
NCT07619365
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
NCT07659678
Asciminib With or Without Sildenafil for Brain Tumors
NCT07039760
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
NCT07620548
ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS
NCT07617363
Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
NCT07300475
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
NCT05521997
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
NCT07593079
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
NCT07545954
Motixafortide for MRD Sensitization in AML
NCT07392970
Low-Count Quantitative SPECT for Men Treated With Radium-223
NCT07221825
Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia
NCT07689162
ENGAGE-TBI Feasibility Study
NCT07549997
Precision Supplemental Imaging in Women With Dense Breasts
NCT07277738
Overcoming Racial Disparities in Screening Mammography
NCT07549139
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT07552558
Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
NCT07101666
Feasibility of SUPPORT-TBI
NCT07625098
Psilocybin-Assisted Therapy as a Treatment for Depression
NCT07582120
Weight Gain in Pediatric Leukemia Survivors
NCT07374315
Improving Cancer Prevention and Control Through Academic-local Public Health Department Partnerships
NCT06605196
Transcutaneous Auricular Vagus Nerve Stimulation for Attenuation of Inflammatory Response and Blood Pressure in Type B Aortic Dissection
NCT07534722
IMAT Quality in Aging
NCT07506681
Eating Disorder Chatbot Optimization
NCT07218302
Nebulized Nasal Steroids
NCT07270302
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NCT07168148
National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics
NCT07020234
Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate
NCT05458960
Vagus Auricular Stimulation for Tinnitus
NCT06821893
Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention
NCT06562439
Promotion of RSV Immunization Through Multiple Efforts
NCT06640868
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
NCT06547112
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
NCT06582849
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.